<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="3889">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on February 08, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04659135</url>
  </required_header>
  <id_info>
    <org_study_id>Pro00014181</org_study_id>
    <nct_id>NCT04659135</nct_id>
  </id_info>
  <brief_title>ASCO Survey on COVID-19 in Oncology (ASCO) Registry</brief_title>
  <official_title>ASCO Survey on Coronavirus Disease 2019 (COVID-19) in Oncology (ASCO) Registry</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>American Society of Clinical Oncology</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>American Society of Clinical Oncology</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The American Society of Clinical Oncology (ASCO) Survey on Coronavirus 2019 (COVID-19) in&#xD;
      Oncology Registry (ASCO Registry) aims to help the cancer community learn more about the&#xD;
      patterns of symptoms and severity of COVID-19 among patients with cancer, as well as how&#xD;
      COVID-19 is impacting the delivery of cancer care and patient outcomes. The ASCO Registry is&#xD;
      designed to collect both baseline and follow-up data on how the virus impacts cancer care and&#xD;
      cancer patient outcomes during the COVID-19 pandemic and into 2021.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Rationale:&#xD;
&#xD;
      The COVID-19 Pandemic presents a unique opportunity to capture information on how a disease&#xD;
      outbreak affects delivery of high-quality cancer care. ASCO is providing the means for the&#xD;
      oncology community to rapidly submit data that will inform both current cancer care and&#xD;
      provide information to help guide decision-making for future disease outbreaks. While other&#xD;
      entities have launched COVID-19 cancer registries, ASCO's registry collects information about&#xD;
      patients undergoing treatment for cancer and with confirmed COVID-19 infection based on a&#xD;
      positive test. Unlike other registries, ASCO's registry collects follow-up information on&#xD;
      both COVID-19 disease and cancer outcomes at 30-day intervals for the first 90 days and&#xD;
      90-day intervals thereafter up to one year after COVID-19 diagnosis.&#xD;
&#xD;
      Project Objectives:&#xD;
&#xD;
      Capture and describe cancer and COVID-19 status at COVID-19 diagnosis, and cancer and&#xD;
      COVID-19 outcomes of patients with cancer and COVID-19 from participating cancer&#xD;
      practices/institutions. Data collected includes treatment approaches, cancer status, changes&#xD;
      to cancer treatment plans in patients with confirmed severe acute respiratory syndrome&#xD;
      coronavirus 2 (SARS-CoV-2) infection, status of COVID-19 infection (e.g., severity of&#xD;
      symptoms, need for ventilator, hospitalization, etc.) and cancer (e.g., cancer progression,&#xD;
      treatment-related changes/modifications, etc.).&#xD;
&#xD;
      Research Objectives:&#xD;
&#xD;
      Objective 1: Describe the distribution of symptoms and severity of COVID-19 among patients&#xD;
      with cancer (on active treatment or on adjuvant treatment within 12 months after surgical&#xD;
      resection) who have confirmed infection of SARS-CoV-2 •Objective 1.1: Describe distribution&#xD;
      of symptoms and severity of COVID-19 stratified according to demographic characteristics,&#xD;
      including age, cancer type, cancer extent, race, ethnicity, geography, type of therapy&#xD;
      received, smoking status, comorbidities, etc.&#xD;
&#xD;
      •Objective 1.2: Identify characteristics independently associated with severity of COVID-19&#xD;
      in cancer patients.&#xD;
&#xD;
      Objective 2: Examine SARS-CoV-2 viral infection outcomes (ongoing, recovery, hospitalized,&#xD;
      not in ICU; hospitalized in ICU; placed on ventilator; death due to COVID-19 disease&#xD;
      complications) and cancer outcomes (stable, response to treatment, progression, delayed&#xD;
      treatment, treatment discontinued, and death)&#xD;
&#xD;
        -  Objective 2.1: Stratify patients with SARS-CoV-2 viral infection according to&#xD;
           characteristics described in Objective 1.1 to examine whether any of the characteristics&#xD;
           are independently associated with COVID-19 and/or cancer outcomes&#xD;
&#xD;
        -  Objective 2.2: Examine the relationship between SARS-CoV-2 viral infection outcomes and&#xD;
           cancer outcomes and whether SARS-CoV-2 viral infection outcomes are independently&#xD;
           associated with cancer outcomes&#xD;
&#xD;
      Objective 3: To describe effects of the COVID-19 pandemic on cancer practices in the U.S.,&#xD;
      including changes in staffing and resource availability, priorities for patient care, and&#xD;
      modification of interactions between care providers and patients (including use of&#xD;
      telemedicine)&#xD;
&#xD;
      Eligibility Criteria:&#xD;
&#xD;
      The registry collects data about patients with a cancer diagnosis who have a confirmed&#xD;
      SARS-CoV-2 infection and are being treated at participating cancer practices/institutions&#xD;
      within the United States. Patients in one of the four categories are eligible:&#xD;
&#xD;
        1. Patients with a new cancer diagnosis and in the process of cancer staging and/or receipt&#xD;
           of initial cancer therapy&#xD;
&#xD;
        2. Patients with clinically evident cancer receiving anti-cancer treatment,&#xD;
&#xD;
        3. Patients who are disease free, but receiving any type of adjuvant therapy within 1 year&#xD;
           following surgical resection (including hormonal treatments), and&#xD;
&#xD;
        4. Patients with clinically evident cancer receiving supportive care only.&#xD;
&#xD;
      Statistical Considerations and Reporting:&#xD;
&#xD;
      ASCO's Center for Research and Analytics (CENTRA) will periodically create reports to share&#xD;
      with participating practices and the general cancer community, and submit manuscripts for&#xD;
      publication. Reports will summarize overall data and stratified by patient characteristics,&#xD;
      such as disease sites and stage, age and comorbidities. Reports or publications will also&#xD;
      include cancer treatment delay and discontinuation of cancer treatments including surgery,&#xD;
      radiation and drug-based therapies, due to the patient's COVID-19 disease and to other&#xD;
      factors, with stratification by other variables as described above. Changes in practice&#xD;
      patterns of care, staffing, resources, and interactions with patients will also be evaluated&#xD;
      and summarized.&#xD;
&#xD;
      As there is no hypothesis testing planned, there is no required sample size and providing&#xD;
      reports also provided to other registries, with cumulative information, will not affect&#xD;
      validity of results. Confidence intervals will be provided where appropriate to demonstrate&#xD;
      precision of estimates.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 19, 2020</start_date>
  <completion_date type="Anticipated">December 2022</completion_date>
  <primary_completion_date type="Anticipated">December 2022</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>12 Months</target_duration>
  <primary_outcome>
    <measure>Changes to Cancer Treatments</measure>
    <time_frame>12 months</time_frame>
    <description>Treatments: Yes vs. no response to changes in reported treatment administration for anti-cancer therapeutics</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>All-cause mortality at 30 days</measure>
    <time_frame>30 days</time_frame>
    <description>Any patient deaths that occurred as measured by number of days after COVID-19 diagnosis</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>COVID-19 Symptoms</measure>
    <time_frame>12 months</time_frame>
    <description>Yes vs. no response to reported COVID-19 symptoms</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>COVID-19 Treatments</measure>
    <time_frame>12 months</time_frame>
    <description>Yes vs. no response to reported treatment administration for anti-COVID-19 therapeutics</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient vital status</measure>
    <time_frame>12 months</time_frame>
    <description>Alive vs. dead at 12 months from COVID-19 diagnosis</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Overall survival</measure>
    <time_frame>12 months</time_frame>
    <description>Time to event endpoint measured as the time from covid-19 dx to death, censored at the last time patient was known to be alive if there is no death date provided.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient cancer status (for patients who had active cancer at covid-19 dx)</measure>
    <time_frame>12 months</time_frame>
    <description>Categorical variable of cancer status, compared to time at COVID-19 diagnosis (stable, responding to therapy, progressed). This will be measured over time (longitudinally) and can take different values for the same patient at different time points.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient cancer status (for patients who are disease-free at COVID-19 diagnosis)</measure>
    <time_frame>12 months</time_frame>
    <description>An indicator (yes v no) of whether the patients cancer has relapsed since COVID-19 diagnosis. This will be measured over time (longitudinally) and can take different values for the same patient at different time points.</description>
  </secondary_outcome>
  <enrollment type="Anticipated">2000</enrollment>
  <condition>Neoplasms</condition>
  <condition>Coronavirus</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with a cancer diagnosis who have a confirmed SARS-CoV-2 infection and are being&#xD;
        treated for their cancer at participating cancer practices/institutions within the United&#xD;
        States&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  COVID-19 positive diagnosis&#xD;
&#xD;
          -  One of the following;&#xD;
&#xD;
               1. Patient has active cancer at the time of COVID-19 diagnosis OR&#xD;
&#xD;
               2. Patient has been cancer-free for less than 12 months AND receiving adjuvant&#xD;
                  therapy at the time of COVID-19 diagnosis&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  COVID-19 suspected, but no positive test result&#xD;
&#xD;
          -  Patient is a cancer-free not receiving any anti-cancer or adjuvant treatment&#xD;
&#xD;
          -  Patient is receiving adjuvant therapy, but has been cancer-free for more than 12&#xD;
             months at the time of COVID-19 diagnosis&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Richard L Schilsky, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>American Society of Clinical Oncology</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Suanna S Bruinooge, MPH</last_name>
    <role>Study Director</role>
    <affiliation>American Society of Clinical Oncology</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Elizabeth Garrett-Mayer, PhD</last_name>
    <role>Study Director</role>
    <affiliation>American Society of Clinical Oncology</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jen H Williams, MA</last_name>
    <phone>571-483-3000</phone>
    <email>centra@asco.org</email>
  </overall_contact>
  <location>
    <facility>
      <name>Anchorage Oncology Center</name>
      <address>
        <city>Anchorage</city>
        <state>Alaska</state>
        <zip>99508</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Latha Subramanian</last_name>
      <email>2006anch@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>AIS Cancer Center</name>
      <address>
        <city>Bakersfield</city>
        <state>California</state>
        <zip>93301</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Brandon Bennett</last_name>
      <email>BennetB1@ah.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Long Beach Memorial Medical Center</name>
      <address>
        <city>Fountain Valley</city>
        <state>California</state>
        <zip>92708</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Milan Sheth</last_name>
      <email>msheth@memorialcare.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Orange Coast Medical Center</name>
      <address>
        <city>Fountain Valley</city>
        <state>California</state>
        <zip>92708</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Amol Rao</last_name>
      <email>amolraomd@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Saddleback Memorial Medical Center</name>
      <address>
        <city>Fountain Valley</city>
        <state>California</state>
        <zip>92708</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Amol Rao</last_name>
      <email>amolraomd@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Helen Diller Family Comprehensive Cancer Center, UCSF</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94118</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eric Small</last_name>
      <email>Eric.Small@ucsf.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Gene Upshaw Memorial Tahoe Forest Cancer Center</name>
      <address>
        <city>Truckee</city>
        <state>California</state>
        <zip>96161</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Scott Baker</last_name>
      <email>sbaker@TFHD.COM</email>
    </contact>
    <contact_backup>
      <last_name>Thomas Semrad</last_name>
      <email>tsemrad@TFHD.COM</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>PIH Health</name>
      <address>
        <city>Whittier</city>
        <state>California</state>
        <zip>90602</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rosie Drulias</last_name>
      <email>Rosie.Drulias@pihhealth.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Sarah Cannon Research Institute at HealthONE</name>
      <address>
        <city>Denver</city>
        <state>Colorado</state>
        <zip>80218</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Margaret Mazzone</last_name>
      <email>meg.mazzone@sarahcannon.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hartford HealthCare Cancer Institute</name>
      <address>
        <city>Hartford</city>
        <state>Connecticut</state>
        <zip>06102</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Peter Yu</last_name>
      <email>Peter.Yu@hhchealth.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Bayhealth Medical Center</name>
      <address>
        <city>Dover</city>
        <state>Delaware</state>
        <zip>19901</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stephanie McClellan</last_name>
      <email>Stephanie_McClellan@bayhealth.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Florida Precision Oncology, A Division of 21st Centry Oncology</name>
      <address>
        <city>Fort Myers</city>
        <state>Florida</state>
        <zip>33907</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rudi Ross</last_name>
      <email>Rudi.Ross@21co.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Florida Cancer Specialists &amp; Research Institute, LLC</name>
      <address>
        <city>Sarasota</city>
        <state>Florida</state>
        <zip>34236</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Margaret Mazzone</last_name>
      <email>meg.mazzone@sarahcannon.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Emory University Winship Cancer Institute</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30322</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>R. Donald Harvey, PharmD</last_name>
      <email>rdharve@emory.edu</email>
    </contact>
    <investigator>
      <last_name>R. Donald Harvey, PharmD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Augusta University</name>
      <address>
        <city>Augusta</city>
        <state>Georgia</state>
        <zip>30912</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ihab Azab</last_name>
      <email>IAZAB@augusta.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hawaii Cancer Care</name>
      <address>
        <city>Honolulu</city>
        <state>Hawaii</state>
        <zip>96813</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mandy Joosten</last_name>
      <email>mandy.joosten@hawaiicancercare.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>NorthShore University HealthSystem</name>
      <address>
        <city>Evanston</city>
        <state>Illinois</state>
        <zip>60201</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michelle Britto</last_name>
      <email>MBritto@northshore.org</email>
    </contact>
    <investigator>
      <last_name>Poornima Saha</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Joliet Oncology-Hematology Associates</name>
      <address>
        <city>Joliet</city>
        <state>Illinois</state>
        <zip>60435</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Karen Sceniak</last_name>
      <email>ksceniak@jolietoncology.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Edward-Elmhurst Healthcare</name>
      <address>
        <city>Naperville</city>
        <state>Illinois</state>
        <zip>60540</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sandra Guy</last_name>
      <email>Sandra.Guy@EEHealth.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Illinois Cancer Care</name>
      <address>
        <city>Peoria</city>
        <state>Illinois</state>
        <zip>61615</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jamie Harper</last_name>
      <email>jharper@illinoiscancercare.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Goshen Center for Cancer Care</name>
      <address>
        <city>Goshen</city>
        <state>Indiana</state>
        <zip>46526</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kelly Hattery</last_name>
      <email>khattery@goshenhealth.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Michiana Hematology Oncology</name>
      <address>
        <city>Mishawaka</city>
        <state>Indiana</state>
        <zip>46545</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dara Richie</last_name>
      <email>DRichie@mhopc.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>MidAmerica Oncology Associates</name>
      <address>
        <city>Overland Park</city>
        <state>Kansas</state>
        <zip>66215</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Margaret Mazzone</last_name>
      <email>meg.mazzone@sarahcannon.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Kansas Medical Center</name>
      <address>
        <city>Westwood</city>
        <state>Kansas</state>
        <zip>66205</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Adam Al Douri</last_name>
      <email>aaldouri@kumc.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Baptist Health Madisonville</name>
      <address>
        <city>Madisonville</city>
        <state>Kentucky</state>
        <zip>42431</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Susan Knight</last_name>
      <email>susan.knight@bhsi.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Greater Baltimore Medical Center</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21204</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nicole Fowler</last_name>
      <email>nfowler@gbmc.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>LifeBridge Health</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21215</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ashley Jones</last_name>
      <email>Anjones@lifebridgehealth.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Tufts Medical Center</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02111</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hailey Johnson</last_name>
      <email>hjohnson1@tuftsmedicalcenter.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Great Lakes Cancer Management Specialists</name>
      <address>
        <city>Grosse Pointe Woods</city>
        <state>Michigan</state>
        <zip>48236</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nancy Studier</last_name>
      <email>nancy.studier@ascension.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Lakeland Hospitals</name>
      <address>
        <city>Saint Joseph</city>
        <state>Michigan</state>
        <zip>49085</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Melanie Meehan</last_name>
      <email>MMeehan1@lakelandhealth.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Mayo Clinic</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55905</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thorvardur Halfdanarson</last_name>
      <email>Halfdanarson.Thorvardur@mayo.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Mosaic Cancer Care</name>
      <address>
        <city>Saint Joseph</city>
        <state>Missouri</state>
        <zip>64507</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christy Hughes</last_name>
      <email>Christy.Hughes@mymlc.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Nebraska Hematology Oncology</name>
      <address>
        <city>Lincoln</city>
        <state>Nebraska</state>
        <zip>68506</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kent Disney</last_name>
      <email>kdisney@yourcancercare.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Callahan Cancer Center</name>
      <address>
        <city>North Platte</city>
        <state>Nebraska</state>
        <zip>69101</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lisa Kosmacek</last_name>
      <email>kosmacekl@gphealth.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Nebraska Cancer Specialists</name>
      <address>
        <city>Omaha</city>
        <state>Nebraska</state>
        <zip>68130</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Danielle Geiger</last_name>
      <email>dgeiger@nebraskacancer.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Nebraska Medical Center</name>
      <address>
        <city>Omaha</city>
        <state>Nebraska</state>
        <zip>68198</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Debbie Vidlak</last_name>
      <email>dvidlak@unmc.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Bayonne Medical Center</name>
      <address>
        <city>Bayonne</city>
        <state>New Jersey</state>
        <zip>07002</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Uzma Rizwan</last_name>
      <email>Uzma.Rizwan@CarePointhealth.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CarePoint Health - Christ Hospital</name>
      <address>
        <city>Jersey City</city>
        <state>New Jersey</state>
        <zip>07306</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Uzma Rizwan</last_name>
      <email>Uzma.Rizwan@CarePointhealth.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Penn Medicine, Princeton Health</name>
      <address>
        <city>Plainsboro</city>
        <state>New Jersey</state>
        <zip>08536</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tina Inverso</last_name>
      <email>tina.inverso@PennMedicine.Upenn.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hematology Oncology Associates of Central New York</name>
      <address>
        <city>East Syracuse</city>
        <state>New York</state>
        <zip>13057</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Matthew Korzeniewski</last_name>
      <email>mkorzeniewski@Hoacny.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Northwell Health Cancer Institute</name>
      <address>
        <city>Lake Success</city>
        <state>New York</state>
        <zip>11042</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wasif Saif</last_name>
      <email>wsaif@northwell.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of North Carolina at Chapel Hill</name>
      <address>
        <city>Chapel Hill</city>
        <state>North Carolina</state>
        <zip>27599</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Williams Wood</last_name>
      <email>william_wood@med.unc.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Levine Cancer Institute Atrium Health</name>
      <address>
        <city>Charlotte</city>
        <state>North Carolina</state>
        <zip>28204</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kathryn Mileham</last_name>
      <email>Kathryn.Mileham@atriumhealth.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>East Carolina University</name>
      <address>
        <city>Greenville</city>
        <state>North Carolina</state>
        <zip>27858</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kevin Mills</last_name>
      <email>MILLSK@ECU.EDU</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Carteret Health Care</name>
      <address>
        <city>Morehead City</city>
        <state>North Carolina</state>
        <zip>28557</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Matthew Carter</last_name>
      <email>mscarter@carterethealth.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CarolinaEast Medical Center</name>
      <address>
        <city>New Bern</city>
        <state>North Carolina</state>
        <zip>28560</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lynn Harrison</last_name>
      <email>LHarrison@carolinaeasthealth.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Aultman Hospital</name>
      <address>
        <city>Canton</city>
        <state>Ohio</state>
        <zip>44710</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mary Amos</last_name>
      <email>Mary.Amos@aultman.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Cincinnati Children's Hospital</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45229</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lori Backus</last_name>
      <email>Lori.Backus@cchmc.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Oncology Hematology Care</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45242</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eric Clayton</last_name>
      <email>Eric.Clayton@usoncology.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Florida Cancer Specialists</name>
      <address>
        <city>Massillon</city>
        <state>Ohio</state>
        <zip>44646</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tara Barker</last_name>
      <email>tbarker@tricountyassoc.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Columbia Memorial Hospital</name>
      <address>
        <city>Astoria</city>
        <state>Oregon</state>
        <zip>97103</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christopher Laman</last_name>
      <email>claman@columbiamemorial.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Samaritan Health Services Corvallis</name>
      <address>
        <city>Corvallis</city>
        <state>Oregon</state>
        <zip>97330</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anthony Franklin</last_name>
      <email>anfranklin@samhealth.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Penn Medicine, Lancaster General Health</name>
      <address>
        <city>Lancaster</city>
        <state>Pennsylvania</state>
        <zip>17604</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Brenda Groff</last_name>
      <email>brenda.groff@pennmedicine.upenn.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Pennsylvania</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Charu Aggarwal</last_name>
      <email>charu.aggarwal@pennmedicine.upenn.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Thomas Jefferson University</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19107</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christopher McNair</last_name>
      <email>Christopher.McNair@jefferson.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Fox Chase Cancer Center</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19111</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kimberly Maher</last_name>
      <email>Kimberly.Maher@fccc.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Monument Health</name>
      <address>
        <city>Rapid City</city>
        <state>South Dakota</state>
        <zip>57701</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Angie Dunbar</last_name>
      <email>ADunbar@monument.health</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Baptist Clinical Research Institute</name>
      <address>
        <city>Memphis</city>
        <state>Tennessee</state>
        <zip>38120</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Philip Lammers</last_name>
      <email>Philip.Lammers@bmg.md</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Tennessee Oncology</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37203</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Margaret Mazzone</last_name>
      <email>meg.mazzone@sarahcannon.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>BSA Harrington Cancer Center</name>
      <address>
        <city>Amarillo</city>
        <state>Texas</state>
        <zip>79106</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gina Cravey</last_name>
      <email>gcravey@harringtoncc.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Virginia Cancer Specialists</name>
      <address>
        <city>Fairfax</city>
        <state>Virginia</state>
        <zip>22031</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexander Spira</last_name>
      <email>alexander.spira@usoncology.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hematology Oncology Associates of Fredericksburg</name>
      <address>
        <city>Fredericksburg</city>
        <state>Virginia</state>
        <zip>22408</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jennifer Orlando</last_name>
      <email>jorlando@hoafredericksburg.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Virginia Cancer Institute</name>
      <address>
        <city>Richmond</city>
        <state>Virginia</state>
        <zip>23230</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Susan Moore</last_name>
      <email>smoore@vacancer.com</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2020</verification_date>
  <study_first_submitted>November 30, 2020</study_first_submitted>
  <study_first_submitted_qc>December 7, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">December 9, 2020</study_first_posted>
  <last_update_submitted>December 7, 2020</last_update_submitted>
  <last_update_submitted_qc>December 7, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">December 9, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Cancer</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronavirus Infections</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>ASCO will make deidentified Registry data available to researchers (both those at Registry sites and those not involved with the Registry) for further analysis. The timing of data release will depend on the number of cases reported to the registry, and entry of the outcome information. ASCO will review requests for Registry data from individuals and entities that submit a research proposal that complies with ASCO's requirements for data access. ASCO will promote access to information for projects that address the needs of patients with cancer, including marginalized populations and communities. ASCO will promote authenticity, quality, reliability and integrity of information and analyses. ASCO will promote fair access and efficiency in the use and sharing of ASCO Information within the bounds of this Policy.</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_time_frame>Late 2021</ipd_time_frame>
    <ipd_access_criteria>Completion of a satisfactory Research Project Proposal Application, as discussed on the ASCO Data Library website (https://www.asco.org/research-guidelines/center-research-analytics-centra/asco-data-library)</ipd_access_criteria>
    <ipd_url>http://www.asco.org/research-guidelines/center-research-analytics-centra/asco-data-library</ipd_url>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>October 6, 2020</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/35/NCT04659135/Prot_000.pdf</document_url>
    </provided_document>
  </provided_document_section>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

